News

Public · Published

Trifork strengthens its medical software capabilities with MDR certification and CE marking of nationwide medication solution

Trifork Digital Health received CE marking under the EU Medical Device Regulation for its Shared Medication Decision Support (FMB), built with Danish regions and integrated into clinical systems across Denmark. It also obtained MDR certification from BSI for its quality management system.

Published:

Updated:

What happened

Trifork Digital Health received CE marking under the EU Medical Device Regulation for its Shared Medication Decision Support (FMB), built with Danish regions and integrated into clinical systems across Denmark. It also obtained MDR certification from BSI for its quality management system.

Confirmed

Global impact / market context

The certification lets Trifork sell regulated medical software to more customers, since CE marking is required to market a medical device in the EU. That could open new revenue from hospitals and health systems while raising costs tied to regulatory compliance and quality controls.

Analyst inference

Medical software is moving into formal device regulation, which means companies need certified quality systems to compete for hospital contracts. Trifork is positioning itself in that regulated niche, where approvals act as a barrier to entry and can support steadier recurring revenue from healthcare customers.

Analyst inference

What to watch

  1. Trifork says FMB integrates into clinical systems doctors already use and gives patient-specific medication decision support, which is a Class IIa medical device under EU rules. Confirmed
  2. Watch whether Trifork signs new customer contracts for regulated medical device software, since the company says the BSI certification supports its ability to develop such software for other customers. Proposed
  3. Track spending on regulatory compliance and quality management, because keeping MDR certification adds ongoing costs that could weigh on profit per sale from this medical software business. Analyst inference

Evidence